Company profile: PCAS
1.1 - Company Overview
Company description
- Provider of technology-oriented fine chemical development and production services, specializing in processes and complex molecule manufacturing for Life Sciences and Specialty Chemicals markets. Serving global industrial customers since 1962, with a focus on safety, reliability, and compliance with sustainable development, ISO, and GMP regulations.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PCAS
Ipsen
HQ: France
Website
- Description: Provider of specialty-driven biopharmaceutical therapies, developing and commercializing innovative medicines in oncology, neuroscience, and rare disease. Offers treatments for cancer (including prostate cancer), neurological conditions, and rare diseases; invests in R&D and conducts clinical trials to evaluate safety and efficacy and advance new therapeutic solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ipsen company profile →
Southwood Research
HQ: United Kingdom
Website
- Description: Provider of pre-approval regulatory science services to the pharmaceutical and biotech industries, focusing on the science behind each product and delivering strategic clinical and regulatory insight.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Southwood Research company profile →
UBC
HQ: United States
Website
- Description: Provider of pharmaceutical support services for life science companies, including evidence development, safety and risk management, patient access, technology solutions, and clinical services. UBC leverages real-world data, technology, and analytics to enhance late-stage research, demonstrate safety, improve access and adherence, and speed therapy initiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UBC company profile →
Red Nucleus
HQ: United States
Website
- Description: Provider of award-winning e-learning, digital content, and performance solutions for the Life Sciences industry, specializing in professional training, marketing learning systems, and workshops that engage client-facing teams throughout their continuing education journey, with offices in the US, UK, and India.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Red Nucleus company profile →
Provepharm Life Solutions
HQ: France
Website
- Description: Provider of injectable pharmaceutical dyes and services, including methylene blue solutions (PROVEBLUE, PROVAYBLUE) and indigo carmine (Provingo/Bludigo) with authorizations across the US, France, Australia, New Zealand, and South Korea; plus R&D on molecule revitalization, clinical studies to improve API purity and stability, and GMP production of batches for clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Provepharm Life Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PCAS
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PCAS
2.2 - Growth funds investing in similar companies to PCAS
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PCAS
4.2 - Public trading comparable groups for PCAS
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →